Should I buy Intuitive Surgical Inc. (ISRG)?

What Sell means for ISRG today

A Sell rating is the output of the composite fair-value band ($176–$337) compared with the live price ($450), a 9/10 moat score, and a 87/100 confidence reading on the data quality and model convergence behind the fair-value range. We do not issue Buy / Strong Buy unless valuation is in the strong half of our six-factor decision overlay AND the risk profile is non-elevated; the rating is gated, not free-form.

Sell. The 56% divergence from consensus target signals heavy market premium; intrinsic baseline valuation is $254.67. The full report explains every input: discount rate, terminal growth, deceleration curve, scenario probabilities, and where the rating could change next.

Bull, base and bear over our base horizon

Bull case (probability 20%): target $336.56, return -25.2%. Base case (probability 60%): target $254.67, return -43.4%. Bear case (probability 20%): target $175.51, return -61.0%.

Probability weights are not symmetric. Intuitive Surgical Inc. is a mature compounder stock, so the deceleration curve, terminal P/E, and confidence in the bull tail are calibrated to that archetype. The probability-weighted expected value in the full report folds these three scenarios into a single asymmetric expected return — a more honest "should I buy?" signal than any single point estimate.

Risks to the thesis

The top kill-scenarios our latest report flags for Intuitive Surgical Inc. are: Medtronic/J&J Capture 30% Market Share; Severe Hospital Capex Freeze; New Modality Disruption. The single biggest risk is Medtronic/J&J Capture 30% Market Share: Competitors successfully disrupt the monopoly, forcing severe pricing pressure on systems and instruments.

The biggest opportunity is Bull: Flawless execution of new product pipelines and sustained international expansion justify a premium 30x+ multiple, reaching consensus expected value. Position management in the full report converts the rating into concrete checkpoints — quarterly reassessment triggers and the metric thresholds that should change the size of the position rather than the position itself.

Bottom line

Our Sell rating with 87/100 confidence is research for educational purposes — not personalised investment advice and not a price call. Use the fair-value range and the bull/base/bear distribution to size a view; use the kill-scenarios and the earnings decision tree to define what would invalidate it.

For the full evidence — 14 sections, sensitivity grid, scorecard, and the data-provenance appendix — see the canonical report at /stocks/isrg/analysis.

Frequently asked questions